Vaccination against human papillomavirus: A baseline survey of Canadian clinicians' knowledge, attitudes and beliefs

Vaccine

Volumn 25, Issue 45, 2007, Pages 7841-7847

  Duval, Bernard ^a   Gilca, Vladimir ^a   McNeil, Shelly ^b   Dobson, Simon ^c   Money, Deborah ^c   Gemmill, Ian M ^d   Sauvageau, Chantal ^a   Lavoie, France ^a   Ouakki, Manale ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Kingston   (Canada)

Author keywords

Attitudes; Beliefs; Human papillomavirus; Knowledge; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CANADA; FEMALE; GENERAL PRACTITIONER; HEALTH PROGRAM; HUMAN; INFECTION PREVENTION; NONHUMAN; PEDIATRICIAN; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; VACCINATION; VERRUCA VULGARIS; WART VIRUS;

DATA COLLECTION; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PEDIATRICS; PHYSICIANS, FAMILY; QUESTIONNAIRES; VACCINATION;

EID: 35348965223     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.08.041     Document Type: Article

References (28)

1. Schiffman M., and Castle P.E. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 127 8 (2003) 930-934
2. Trottier H., and Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine (2005) S1/4-S1/10
3. Franco E., and Harper D.M. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 23 17-18 (2005) 2388-2394
4. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Eng J Med 348 6 (2003) 518-527
5. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6 5 (2005) 271-278
6. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Paavonen J., Iversen O.E., et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 95 11 (2006) 1459-1466 Epub 2006 Nov 21
7. Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364 9447 (2004) 1757-1765
8. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006)
9. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007 Mar-Apr;57(2):75-89. Erratum in: CA Cancer J Clin 2007 May-Jun;57(3):185.
10. Goldie S.J., Kohli M., Grima D., Weinstein M.C., Wright T.C., Bosch F.X., et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 96 8 (2004) 604-615
11. Adams M., Jasani B., and Fiander A. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine 25 16 (2007) 3007-3013
12. Marlow L.A., Waller J., and Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 25 11 (2007) 1945-1952
13. Zimet G.D., Mays R.M., and Fortenberry J.D. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm. Dis. 27 1 (2000) 49-52
14. Riedesel J.M., Rosenthal S.L., Zimet G.D., Bernstein D.I., Huang B., Lan D., et al. Attitudes about Human Papillomavirus Vaccine among Family Physicians. J Pediatr Adolesc Gynecol (2005) 391-398
15. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 37 6 (2005) 502-510
16. Raley J.C., Followwill K.A., Zimet G.D., and Ault K.A. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 12 3-4 (2004) 127-133
17. Zimet G.D., Liddon N., Rosenthal S.L., Lazcano-Ponce E., and Allen B. Chapter 24: Psychosocial aspects of vaccine acceptability. Vaccine 24 Suppl 3 (2006) S201-S209
18. Zimet G.D. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 37 6 Suppl (2005) S17-S23
19. Wright T.C., Bosch F.X., Franco E.L., Cuzick J., Schiller J.T., Garnett G.P., et al. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine 24 Suppl 3 (2006) S251-S261
20. Public Health Agency of Canada, Canadian Human Papillomavirus Vaccine Research Priorities Workshop-Final Report. CCDR (2005) 66 [32S1]
21. Dobson S., Deeks S., and Money D. Déclaration sur le vaccin contre le virus du papillome humain. CCDR RMTC 33 (2007) 32
22. Dillman D.A. Mail and telephone surveys-the total desing method. A Wiley-Interscience Publication ed. (1978), John Wiley & Sons, United States p. 325
23. Dillman D.A. Mail and internet surveys-the tailored design method. 2nd ed. (2000), John Wiley & Sons, New York p. 464
24. Walsh J.M.E., and McPhee S.J. A systems model of clinical preventive care: an analysis of factors influencing patient and physician. Health Educ Q 19 2 (1992) 157-175
25. CMA Masterfile, January 2006, Canadian Medical Association.
26. Huse D.M., Roht L.H., Alpert J.S., and Hartz S.C. Physicians' knowledge, attitudes, and practice of pharmacologic treatment of hypertension. Ann Pharmacother 35 10 (2001) 1173-1179
27. Kellerman S.E., and Herold J. Physician response to surveys. A review of the literature. Am J Prev Med 20 1 (2001) 61-67
28. Armitage C.J., and Conner M. Efficacy of the Theory of Planned Behaviour: a meta-analytic review. Br J Soc Psychol 40 Pt 4 (2001) 471-499